(S (NP (NP (DT The) (NML (NML (NML (NN automation)) (PP (IN of) (NP (JJ adverse) (NN drug) (NN reaction)))) (-LRB- -LRB-) (NML (NN ADR)) (-RRB- -RRB-)) (NN detection)) (PP (IN in) (NP (JJ social) (NNS media)))) (VP (MD would) (VP (VB revolutionize) (NP (NP (DT the) (NN practice)) (PP (IN of) (NP (NN pharmacovigilance)))) (, ,) (S (VP (VBG supporting) (NP (NP (NN drug) (NNS regulators)) (, ,) (NP (DT the) (JJ pharmaceutical) (NN industry)) (CC and) (NP (DT the) (JJ general) (NN public))) (PP (IN in) (S (VP (VBG ensuring) (NP (NP (DT the) (NN safety)) (PP (IN of) (NP (NP (DT the) (NNS drugs)) (VP (VBN prescribed) (PP (IN in) (NP (JJ daily) (NN practice)))))))))))))) (. .))
(S (PP (VBG Following) (PP (IN from) (NP (NP (DT the) (VBN published) (NNS proceedings)) (PP (IN of) (NP (NP (DT the) (NML (NNP Social) (NNP Media)) (NNP Mining)) (PP (IN for) (NP (NP (NML (NML (NNP Health)) (-LRB- -LRB-) (NML (NN SMM4H)) (-RRB- -RRB-)) (NNS Applications)) (NP (NP (NNP Workshop) (CC &) (NNP Shared) (NNP Task)) (PP (IN in) (NP (NNP August) (CD 2019))))))))))) (, ,) (NP (PRP we)) (VP (VBD aimed) (S (VP (TO to) (VP (VB develop) (NP (DT a) (JJ deep) (NN learning) (NN model)) (S (VP (TO to) (VP (VB classify) (NP (NNS ADRs)) (PP (IN within) (NP (NP (NNP Twitter) (NNS tweets)) (SBAR (WHNP (WDT that)) (S (VP (VBP contain) (SBAR (S (NP (NN drug)) (VP (VBZ mentions)))))))))))))))) (. .))
(S (NP (PRP$ Our) (NN approach)) (VP (VBD involved) (NP (NP (NML (JJ fine) (HYPH -) (NN tuning)) (NML ($ $) (CD BERT))) (NFP _) (NP (ADJP (-LRB- {) (JJ LARGE) (-RRB- })) (NML (NML ($ $)) (CC and) (NML (CD two))) (ADJP (ADJP (NN domain) (HYPH -) (JJ specific)) (SBAR (S (VP (FRAG (FRAG (FRAG (NP (NNP BERT)) (NP (NNS implementations))) (, ,) (FRAG (NP ($ $) (CD BioBERT)) (NP ($ $))) (CC and) (FRAG (NP ($ $)) (NP (NN Bio) (SYM +) (NN clinicalBERT)) (NP ($ $)))) (, ,) (S (VP (VP (VBG applying) (NP (DT a) (ADJP (NN domain) (HYPH -) (JJ specific)) (NN preprocessor))) (, ,) (CC and) (VP (VBG developing) (NP (DT a) (NN max) (HYPH -) (NN prediction)))))))))) (NN ensembling) (NN approach)))) (. .))
(S (NP (PRP$ Our) (JJ final) (NN model)) (VP (VBD resulted) (PP (IN in) (NP (NML (NML (NN state)) (HYPH -) (PP (IN of) (HYPH -) (NP (DT the) (HYPH -) (NN art)))) (NN performance))) (PP (IN on) (NP (NP (DT both) (NML (NML (QP ($ $) (CD F_1))) (NML ($ $))) (HYPH -) (NN score) (PRN (-LRB- -LRB-) (NP (CD 0.6681)) (-RRB- -RRB-))) (CC and) (NP (NN recall) (PRN (-LRB- -LRB-) (NP (CD 0.7700)) (-RRB- -RRB-))))) (S (VP (VBG outperforming) (NP (NP (DT all) (NNS models)) (VP (VBN submitted) (PP (PP (IN in) (NP (NN SMM4H) (CD 2019))) (CC and) (PP (IN during) (NP (NN post-evaluation)))) (PP (IN to) (NP (NN date)))))))) (. .))
